This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2018
  • /
  • 01
  • /
  • Recent approvals of Plenvu bowel cleansing prepara...
Drug news

Recent approvals of Plenvu bowel cleansing preparation.

Read time: 1 mins
Last updated:16th Jan 2018
Published:16th Jan 2018
Source: Pharmawand

Norgine B.V. announced marketing authorisation for Plenvu for bowel cleansing in adults prior to any procedure requiring a clean bowel has been granted by the Austrian, French, Irish, Italian and Portuguese regulatory authorities.

Norgine anticipates launches in these countries in 2018. PLenvu is now approved for use in Austria, Australia, Belgium, Denmark, Finland, France, Iceland, Ireland, Italy, Portugal, The Netherlands and in the UK (known as Plenvue in Austria and Netherlands). Plenvu is available in the UK. Plenvu is a novel, low volume (1-litre) polyethylene glycol (PEG) 3350-based bowel preparation that has been developed by Norgine to provide whole bowel cleansing. Plenvu provides superior high-quality bowel cleansing efficacy (in at least one segment of the colon) compared to two widely used alternative bowel preparations: sodium picosulfate and magnesium salt solution (CitarFleet) and 2-litre PEG with ascorbate (Moviprep).

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.